Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor
- 5 May 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (9) , 1101-1106
- https://doi.org/10.1016/s0960-894x(98)00169-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITYAnnual Review of Medicine, 1997
- The potential role of β3 adrenoceptor agonists In the treatment of obesity and diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- Chapter 20. β3-Selective Adrenergic Receptor AgonistsPublished by Elsevier ,1995
- β3 and Atypical β‐AdrenoceptorsMedicinal Research Reviews, 1993
- Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agentJournal of Medicinal Chemistry, 1992
- Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetatesJournal of Medicinal Chemistry, 1992
- Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 2. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetamidesJournal of Medicinal Chemistry, 1992
- BRL 35135, a potent and selective atypical β-adrenoceptor agonistThe American Journal of Clinical Nutrition, 1992
- Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical adrenoceptor agonistBMJ, 1988
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984